PFMT Pengajuan SEC - Performant Healthcare, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1550695

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Performant Healthcare, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 28, 2025	EX-FILING FEES	CALCULATION OF FILING FEE TABLES SCHEDULE 14A (Form Type) Performant Healthcare, Inc. (Name of Registrant as Specified in its Charter) Table 1: Transaction Value Exhibit 107 CALCULATION OF FILING FEE TABLES SCHEDULE 14A (Form Type) Performant Healthcare, Inc.
August 28, 2025	PREM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by
August 7, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
August 7, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMAN
August 5, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
August 1, 2025	EX-99.1	Performant Healthcare, Inc. To Be Acquired by Machinify EXHIBIT 99.1 Performant Healthcare, Inc. To Be Acquired by Machinify Performant stockholders to receive $7.75 in cash per share, a 139% premium to Performant’s 90-day VWAP PLANTATION, Florida, August 1, 2025 — Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced
August 1, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 Performant Healthc UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 Performant Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commiss
August 1, 2025	EX-2.1	Agreement and Plan of Merger, dated July 31, 2025, by and among Performant Healthcare, Inc., Continental, Buyer, Inc. and Prevail Merger Sub, Inc. EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER by and among CONTINENTAL BUYER, INC., PREVAIL MERGER SUB, INC. and PERFORMANT HEALTHCARE, INC. Dated as of July 31, 2025 TABLE OF CONTENTS Page Article 1 THE MERGER 2 1.1 The Merger 2 1.2 Closing; Effective Time of the Merger 3 Article 2 CONVERSION OF SECURITIES IN THE MERGER 3 2.1 Conversion of Securities 3 2.2 Payment for Securities; Surrender of Certific
August 1, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 Performant Healthc UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 Performant Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commiss
August 1, 2025	EX-99.1	Three Months EXHIBIT 99.1 Performant Healthcare, Inc. Announces Preliminary Financial Results for Second Quarter 2025 Plantation, Florida, August 1, 2025 — Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, today announced preliminary financial results for the second quarter of 2025
June 23, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2025 Performant Healthca UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2025 Performant Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commissi
May 9, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMA
May 8, 2025	EX-99.1	PERFORMANT HEALTHCARE, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amounts) Exhibit 99.1 Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025 Plantation, FL., May 8, 2025 - Performant Healthcare, Inc. (Nasdaq: PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2025: First Quarter 2025 Financial Highlights •Total revenue of $33.3 million, compared
May 8, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Performant Healthcare UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Performant Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commission
April 28, 2025	DEFA14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to § 240.
April 24, 2025	DEF 14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to § 240.
March 13, 2025	EX-19.1	Insider Trading and Communications Policy Exhibit 19.1 INSIDER TRADING AND COMMUNICATIONS POLICY DOCUMENT ID: *** EFFECTIVE DATE: NOVEMBER 23, 2024 EXECUTIVE AUTHORITY: BOARD OF DIRECTORS PURPOSE Performant Healthcare, Inc.(the “Company”) has adopted this Insider Trading and Communications Policy to avoid even the appearance of improper conduct on the part of anyone employed by or associated with the Company (not just so-called insiders).
March 13, 2025	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, LLC. California
March 13, 2025	EX-97.1	Performant Financial Corporation Incentive-Based Compensation Recoupment Policy Exhibit 97.1 PERFORMANT FINANCIAL CORPORATION INCENTIVE-BASED COMPENSATION RECOUPMENT POLICY 1.Purpose The Board of Directors (the “Board”) of Performant Financial Corporation, a Delaware corporation (the “Company”), has adopted this Incentive-Based Compensation Recoupment Policy (this “Policy”) to comply with Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as
March 13, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT HEA
March 12, 2025	EX-99.1	PERFORMANT HEALTHCARE, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) As of December 31, Assets 2024 2023 Current assets: Cash and cash equivalents $ 9,292 $ 7,252 Restricted cash — 81 Trade acc Exhibit 99.1 Performant Healthcare, Inc. Announces Financial Results for Fourth Quarter and Full Year 2024 Plantation, FL, March 12, 2025 - Performant Healthcare, Inc. (Nasdaq: PHLT), a leading provider of healthcare payment integrity services, today reported the following financial results for its fourth quarter and full year ended December 31, 2024: Fourth Quarter 2024 Financial Highlights •Tota
March 12, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 Performant Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commiss
December 10, 2024	EX-3.2	Second Amended and Restated Bylaws of Registrant. Exhibit 3.2 SECOND AMENDED AND RESTATED B Y L A W S OF PERFORMANT HEALTHCARE, INC. (a Delaware corporation) TABLE OF CONTENTS (continued) Page TABLE OF CONTENTS Page ARTICLE 1 Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 ARTICLE 2 Meeting of Stockholders 1 2.1 Place of Meeting 1 2.2 Annual Meeting 1 2.3 Special Meetings 4 2.4 Notice of Meetings 4 2.5 List of Stockholders 5 2.6 Organizatio
December 10, 2024	EX-3.1	Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Registrant. Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PERFORMANT FINANCIAL CORPORATION PERFORMANT FINANCIAL CORPORATION (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY AS FOLLOWS: FIRST: The Corporation filed its original Certificate of Incorporation with the Secre
December 10, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2024 Performant Healt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2024 Performant Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
November 15, 2024	SC 13G/A	PFMT / Performant Financial Corporation / Topline Capital Management, LLC - SC 13G/A Passive Investment SC 13G/A 1 d883754dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) Performant Financial Corp. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 71377E105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of Statement) Check the appropriate box to
November 15, 2024	EX-99.A	JOINT FILING UNDERTAKING EX-99.A 2 d883754dex99a.htm EX-99.A EXHIBIT A JOINT FILING UNDERTAKING The undersigned, being authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule, as it may be amended, jointly on behalf of each of such
November 14, 2024	SC 13G/A	PFMT / Performant Financial Corporation / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment SC 13G/A 1 pfmt-sc13ga093024.htm AMENDMENT TO FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 3) Performant Financial Corp. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 71377E105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this St
November 14, 2024	EX-99.A	JOINT FILING AGREEMENT EX-99.A 2 ex99-a.htm JOINT FILING AGREEMENT CUSIP No . 71377E105 Page 7 of 7 Exhibit A JOINT FILING AGREEMENT The Undersigned agree that the statement on Schedule 13G with respect to the common stock of Performant Financial Corp., dated as of November 14, 2024 is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance wit
November 7, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERF
November 6, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
November 6, 2024	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third Quarter 2024 Plantation, FL., November 6, 2024 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its third quarter ended September 30, 2024: Third Quarter Financial Highlights •Healthcare revenues of $30
August 20, 2024	CORRESP	PERFORMANT FINANCIAL CORPORATION 900 South Pine Island Road Plantation, Florida 33324 August 20, 2024 PERFORMANT FINANCIAL CORPORATION 900 South Pine Island Road Plantation, Florida 33324 August 20, 2024 VIA FACSIMILE AND ELECTRONIC SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
August 14, 2024	EX-4.1	Form of Indenture relating to debt securities. Exhibit 4.1 PERFORMANT FINANCIAL CORPORATION TO [ ] Trustee Indenture Dated as of , 20[●] PERFORMANT FINANCIAL CORPORATION Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of , 20[●] Trust Indenture Indenture Act Section Sections § 310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608 610 § 311(a) 613(a) (b) 613(b) (b)(2) 703(a)(2
August 14, 2024	EX-FILING FEES	Calculation of Filing Fee Tables EXHIBIT 107 Calculation of Filing Fee Tables S-8 (Form Type) PERFORMANT FINANCIAL CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Common Stock, $0.
August 14, 2024	EX-FILING FEES	Calculation of Filing Fees Tables EXHIBIT 107 Calculation of Filing Fee Table S-3 (Form Type) Performant Financial Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Debt Debt Securities 457(o) (1) (1) (1) Equity Common Stock, $0.
August 14, 2024	S-8	As filed with the Securities and Exchange Commission on August 13, 2024 As filed with the Securities and Exchange Commission on August 13, 2024 Registration No.
August 14, 2024	S-3	As filed with the Securities and Exchange Commission on August 13, 2024 As filed with the Securities and Exchange Commission on August 13, 2024 Registration No.
August 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMAN
August 7, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
August 7, 2024	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2024 Plantation, FL., August 7, 2024 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its second quarter ended June 30, 2024: Second Quarter Financial Highlights •Healthcare revenues of $27.9 m
June 24, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Com
May 8, 2024	DEFA14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to § 240.
May 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMA
May 7, 2024	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except par value amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2024 Plantation, FL., May 7, 2024 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its first quarter ended March 31, 2024: First Quarter Financial Highlights •Healthcare revenues of $25.8 millio
May 7, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
May 1, 2024	EX-10.3	Employment Agreement between Performant Financial Corporation and Rohit Ramchandani, dated April 26, 2024. Exhibit 10.3 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into by and between Performant Financial Corporation, a Delaware corporation (the “Company”) and Rohit Ramchandani (the “Executive”) dated as of April 26, 2024. 1.Position; Place of Work. Effective as of May 5, 2023 (the “Effective Date”) the Executive shall serve as the Company’s Chief Financial Officer (“CFO
May 1, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
May 1, 2024	EX-10.1	Employment Agreement between Performant Financial Corporation and Simeon Kohl, dated April 26, 2024. Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into by and between Performant Financial Corporation, a Delaware corporation (the “Company”) and Simeon Kohl (the “Executive”) dated as of April 26, 2024. 1.Position; Place of Work. Effective as of May 5, 2023 (the “Effective Date”) the Executive shall serve as the Company’s Chief Executive Officer (“CEO”), an
May 1, 2024	EX-10.4	Change in Control and Severance Agreement between Performant Financial Corporation and Rohit Ramchandani, dated April 26, 2024. Exhibit 10.4 PERFORMANT FINANCIAL CORPORATION CHANGE IN CONTROL AND SEVERANCE AGREEMENT This Change in Control Severance Agreement (this “Agreement”) is made and entered into effective as of April 26, 2024 (the “Effective Date”), by and between Rohit Ramchandani (“Executive”) and Performant Financial Corporation, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreem
May 1, 2024	EX-10.2	Change in Control and Severance Agreement between Performant Financial Corporation and Simeon Kohl, dated April 26, 2024. Exhibit 10.2 PERFORMANT FINANCIAL CORPORATION CHANGE IN CONTROL AND SEVERANCE AGREEMENT This Change in Control Severance Agreement (this “Agreement”) is made and entered into effective as of April 26, 2024 (the “Effective Date”), by and between Simeon Kohl (“Executive”) and Performant Financial Corporation, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement ar
April 29, 2024	DEF 14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to § 240.
April 18, 2024	EX-99.A	JOINT FILING UNDERTAKING EX-99.A EXHIBIT A JOINT FILING UNDERTAKING The undersigned, being authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule, as it may be amended, jointly on behalf of each of such parties. Dated: April 18, 20
April 18, 2024	SC 13G	PFMT / Performant Financial Corporation / Topline Capital Management, LLC - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.) Performant Financial Corp. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 71377E105 (CUSIP Number) April 8, 2024 (Date of Event Which Requires Filing of Statement) Check the appropriate box to designate the rule pursuant to which t
March 13, 2024	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, LLC. California
March 13, 2024	EX-97.1	erformant Financial Corporation Incentive Exhibit 97.1 PERFORMANT FINANCIAL CORPORATION INCENTIVE-BASED COMPENSATION RECOUPMENT POLICY 1.Purpose The Board of Directors (the “Board”) of Performant Financial Corporation, a Delaware corporation (the “Company”), has adopted this Incentive-Based Compensation Recoupment Policy (this “Policy”) to comply with Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as
March 13, 2024	EX-3.1	Third Amended and Restated Certificate of Incorporation of Registrant, effective as of August 15, 2012, as filed with the Secretary of State of the State of Delaware Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PERFORMANT FINANCIAL CORPORATION Performant Financial Corporation, a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: FIRST: The name of the corporation is Performant Financial Corporation. SECOND: The original Certificate of Incorporation of the corporation was filed with
March 13, 2024	EX-4.2	Description of Registrant’s Securities Registered under Section 12 of the Securities Exchange Act of 1934 Exhibit 4.2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Performant Financial Corporation (“Performant” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our Common Stock. Description of Common Stock The following description of our Common Stock is a summary and does not purport to
March 13, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT FIN
March 12, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
March 12, 2024	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) As of December 31, Assets 2023 2022 Current assets: Cash and cash equivalents $ 7,252 $ 23,384 Restricted cash 81 81 Tr Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2023 Plantation, FL, March 12, 2024 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its fourth quarter and full year ended December 31, 2023: Fourth Quarter Financial Highlights
March 6, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2024 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Com
February 14, 2024	SC 13G/A	PFMT / Performant Financial Corporation / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment SC 13G/A 1 pfmt-sc13ga123123.htm AMENDMENT TO FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 2) Performant Financial Corp. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Sta
February 14, 2024	EX-99.A	JOINT FILING AGREEMENT EX-99.A 2 ex99-a.htm JOINT FILING AGREEMENT CUSIP No . 71377E105 Page 7 of 7 Exhibit A JOINT FILING AGREEMENT The Undersigned agree that the statement on Schedule 13G with respect to the common stock of Performant Financial Corp., dated as of February 14, 2024, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance wi
February 8, 2024	SC 13G/A	PFMT / Performant Financial Corporation / PARTHENON INVESTORS II. L.P. - SC 13G/A Passive Investment SC 13G/A 1 d21823dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* Performant Financial Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Sta
November 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERF
November 7, 2023	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third Quarter 2023 Plantation, FL., November 7, 2023 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare paym
November 7, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
November 1, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2023 Performant Finan UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
November 1, 2023	EX-10.1	Credit Agreement, dated as of October 27, 2023, among the Company and its subsidiaries party thereto, as borrows, the lenders from time to time party thereto and Wells Fargo Bank, National Association, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed November 1, 2023) EXHIBIT 10.1 CREDIT AGREEMENT by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, as Agent, THE LENDERS THAT ARE PARTIES HERETO as the Lenders, and Performant Financial Corporation and its Subsidiaries signatory hereto from time to time as Borrowers Dated as of October 27,2023 TABLE OF CONTENTS 1. Page DEFINITIONS AND CONSTRUCTION.1 1.1 Definitions 1 1.2 Accounting Terms 45 1.3 Code 46 1.4 Constr
August 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMAN
August 8, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Performant Financi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
August 8, 2023	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2023 Livermore, Calif., August 8, 2023 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), primarily operating under subsidiary Performant Healthcare Solutions, a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the
June 15, 2023	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Com
May 10, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMA
May 9, 2023	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2023 Livermore, Calif., May 9, 2023 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity industry, today reported the following financ
May 9, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
May 9, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Performant Financial UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
May 1, 2023	DEFA14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to § 240.
April 25, 2023	DEF 14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to § 240.
March 20, 2023	SC 13D/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP NUMBER) Phil Frohlich 1924 South Utica Ave., Suite #1120 Tulsa, Oklahoma 74104-6429 (918) 747-3412 (Name, Address
March 17, 2023	EX-4.2	Description of Registrant’s Securities Registered under Section 12 of the Securities Exchange Act of 1934 Exhibit 4.2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Performant Financial Corporation (“Performant” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our Common Stock. Description of Common Stock The following description of our Common Stock is a summary and does not purport to
March 17, 2023	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-35628 CUSIP NUMBER 71377E105 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 17, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT FIN
March 17, 2023	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, LLC. California
March 17, 2023	EX-10.8	First Amendment to Credit Agreement, dated as of March 13, 2023, by and among the Company and the lenders from time to time party thereto and MUFG Union Bank, N.A. Execution Version Exhibit 10.8 First Amendment to Credit Agreement This First Amendment to Credit Agreement (this “Amendment”) dated as of March 13, 2023 (the “First Amendment Effective Date”) is entered into by and among Performant Financial Corporation, a Delaware corporation (the “Borrower”), the guarantors party hereto (the “Guarantors”), the lenders party hereto (the “Lenders”), and MUFG Unio
March 14, 2023	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) Assets December 31, 2022 December 31, 2021 Current assets: Cash and cash equivalents $ 23,384 $ 17,347 Restricted cash Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2022 Livermore, Calif., March 14, 2023 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States, with a focus in the healthcare payment integrity industry, today reported the following fina
March 14, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2023 Performant Financi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2023 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
February 14, 2023	SC 13G/A	PFMT / Performant Financial Corp / Ecmc Group, Inc. - SC 13G/A Passive Investment SC 13G/A 1 tm236432d1sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Performant Financial Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriat
February 8, 2023	SC 13G/A	PFMT / Performant Financial Corp / PARTHENON INVESTORS II. L.P. - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* Performant Financial Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the Appropriate
February 3, 2023	SC 13G/A	PFMT / Performant Financial Corp / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 2) Performant Financial Corp. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 71377E105 (CUSIP Number) January 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur
November 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERF
November 8, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
November 8, 2022	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third Quarter 2022 Livermore, Calif., November 8, 2022 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today reported the fo
August 31, 2022	SC 13D/A	PFMT / Performant Financial Corp / Mill Road Capital II, L.P. - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Performant Financial Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71377E105 (CUSIP Number) Mill Road Capital II, L.P. Attn: Thomas E. Lynch 382 Greenwich Avenue Suite One Greenwich, CT 06830 203-98
August 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMAN
August 8, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2022 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
August 8, 2022	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2022 Livermore, Calif., August 8, 2022 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today reported the fol
June 24, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Com
May 10, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMA
May 9, 2022	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2022 Livermore, Calif., May 9, 2022 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today reported the followi
May 9, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2022 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
May 3, 2022	DEFR14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to ? 240.
April 29, 2022	DEFA14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to ? 240.
April 29, 2022	DEF 14A	SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to ? 240.
March 16, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT FIN
March 16, 2022	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, LLC. California Premiere Credit of North America, LLC. Indiana Healthcare Billing Administrators, LLC. Indiana
March 16, 2022	EX-4.2	Description of Registrant’s Securities Registered under Section 12 of the Securities Exchange Act of 1934 Exhibit 4.2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Performant Financial Corporation (?Performant? or ?our?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): our Common Stock. Description of Common Stock The following description of our Common Stock is a summary and does not purport to
March 15, 2022	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) Assets December 31, 2021 December 31, 2020 Current assets: Cash and cash equivalents $ 17,347 $ 16,043 Restricted cash Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2021; Simeon Kohl Promoted to President of Performant Financial Livermore, Calif., March 15, 2022 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial re
March 15, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2022 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
February 14, 2022	SC 13G/A	PFMT / Performant Financial Corp / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 2) Performant Financial Corp. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu
February 11, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2022 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
February 8, 2022	EX-99.A	JOINT FILING AGREEMENT Exhibit A JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G with respect to the common stock, par value $0.
February 8, 2022	SC 13G/A	PFMT / Performant Financial Corp / PARTHENON INVESTORS II. L.P. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Performant Financial Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 71377E 105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the Appropriate Box to
February 7, 2022	SC 13G/A	PFMT / Performant Financial Corp / Ecmc Group, Inc. - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Performant Financial Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
January 25, 2022	SC 13D/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP NUMBER) Phil Frohlich 1924 South Utica Ave., Suite #1120 Tulsa, Oklahoma 74104-6429 (918) 747-3412 (Name, Address
December 20, 2021	EX-1.1	edit Agreement, dated as of December 17, 2021 among the Company, as borrower, the lenders from time to time party thereto and MUFG Union Bank, N.A., as administrative agent. EX-1.1 2 creditagreement-mufg.htm EX-1.1 Execution Copy Exhibit 1.1 CREDIT AGREEMENT Dated as of December 17, 2021, among PERFORMANT FINANCIAL CORPORATION, as the Borrower, the Guarantors from time to time party hereto, the Lenders from time to time party hereto, and MUFG UNION BANK, N.A., as Administrative Agent MUFG UNION BANK, N.A., as Sole Lead Arranger and Sole Book Runner TABLE OF CONTENTS S
December 20, 2021	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation)
November 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERF
November 9, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
November 9, 2021	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third Quarter 2021 Livermore, Calif., November 9, 2021 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today reported the fo
October 7, 2021	SC 13D/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP NUMBER) Phil Frohlich 1924 South Utica Ave., Suite #1120 Tulsa, Oklahoma 74104-6429 (918) 747-3412 (Name, Address
August 19, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (C
August 19, 2021	EX-1.1	Underwriting Agreement, dated as of August 17, 2021, between the Company and Craig-Hallum Capital Group, EX-1.1 2 ex11-underwritingagreement.htm EX-1.1 Exhibit 1.1 10,525,000 Shares1 Performant Financial Corporation Common Stock, par value $0.0001 per share UNDERWRITING AGREEMENT August 17, 2021 CRAIG-HALLUM CAPITAL GROUP LLC As Representative of the several Underwriters named in Schedule I hereto c/o Craig-Hallum Capital Group LLC 222 South Ninth Street, Suite 350 Minneapolis, Minnesota 55402 Ladies
August 19, 2021	EX-99.1	Performant Financial Corporation Announces Proposed Public Offering of Common Stock Exhibit 99.1 Performant Financial Corporation Announces Proposed Public Offering of Common Stock LIVERMORE, CA., August 17, 2021 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today announced that it h
August 19, 2021	424B5	10,525,000 Shares Performant Financial Corporation Common Stock TABLE OF CONTENTS Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-258178 PROSPECTUS SUPPLEMENT (To Prospectus dated August 12, 2021) 10,525,000 Shares Performant Financial Corporation Common Stock We are offering 10,525,000 shares of common stock. Our common stock is listed on the Nasdaq Global Select Market under the symbol “PFMT.” The last reported sale price of our common sto
August 19, 2021	EX-99.2	Performant Financial Corporation Announces Pricing of Public Offering of Common Stock Exhibit 99.2 Performant Financial Corporation Announces Pricing of Public Offering of Common Stock LIVERMORE, CA., August 18, 2021 - Performant Financial Corporation (Nasdaq: PFMT) (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today announced the pric
August 17, 2021	424B5	SUBJECT TO COMPLETION, DATED AUGUST 17, 2021 TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.
August 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMAN
August 10, 2021	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2021 Livermore, Calif., August 10, 2021 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today reported the fo
August 10, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (C
August 10, 2021	CORRESP	PERFORMANT FINANCIAL CORPORATION 333 North Canyons Parkway Livermore, California 94551 August 10, 2021 CORRESP 1 filename1.htm PERFORMANT FINANCIAL CORPORATION 333 North Canyons Parkway Livermore, California 94551 August 10, 2021 VIA FACSIMILE AND ELECTRONIC SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Performant Financial Corporation - Registration Statement – Form S-3 Registration Number: 333-258178 Ladies and Gentleme
July 26, 2021	S-3	As filed with the Securities and Exchange Commission on July 26, 2021 As filed with the Securities and Exchange Commission on July 26, 2021 Registration No.
July 26, 2021	EX-4.1	Form of Indenture relating to debt securities. PERFORMANT FINANCIAL CORPORATION TO [ ] Trustee Indenture Dated as of , 20[?] PERFORMANT FINANCIAL CORPORATION Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of , 20[?] Trust Indenture Act Section Indenture Sections ? 310(a)(1) 609 (a)(2) 609 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 609 (b) 608 610 ? 311(a) 613(a) (b) 613(b) (b)(2) 703(a)(2) 703(b) ? 3
June 14, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2021 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission File
June 4, 2021	SC 13D/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Cl SC 13D/A 1 sc13daperformant06-03.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP NUMBER) Phil Frohlich 1924 South Utica Ave., Suite #1120 Tulsa, Oklahoma 7410
May 28, 2021	EX-10.1	Amended and Restated Fifth Amendment to Credit Agreement, dated as of May 24, 2021, by and among Performant Business Services, Inc., Premiere Credit of North America, LLC, Performant Financial Corporation, Performant Recovery, Inc., Performant Technologies, LLC and Healthcare Billing Administrators, LLC and ECMC Group, Inc. AMENDED AND RESTATED FIFTH AMENDMENT TO CREDIT AGREEMENT THIS AMENDED AND RESTATED FIFTH AMENDMENT TO CREDIT AGREEMENT (the ?Amendment?), dated as of May 24, 2021, is by and among Performant Business Services, Inc.
May 28, 2021	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2021 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Comm
May 17, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMA
May 13, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Comm
May 13, 2021	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2021 Livermore, Calif., May 13, 2021 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its first quarter ended March 31, 2021: First Qua
April 30, 2021	DEFA14A	- DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to ? 240.
April 30, 2021	DEF 14A	- DEF 14A DEF 14A 1 a2021proxydef.htm DEF 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additi
April 16, 2021	PRE 14A	- PRE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to ? 240.
March 29, 2021	EX-10.1	Amendment No. 5 to Credit Agreement, dated as of March 23, 2021, by and among Performant Business Services, Inc., the Lenders party hereto, and ECMC Group, Inc. Exhibit 10.1 Execution Version Fifth Amendment to Credit Agreement This Fifth Amendment to Credit Agreement (the ?Amendment?), dated as of March 23, 2021, is by and among Performant Business Services, Inc., a Nevada corporation (?PBS?) and Premiere Credit of North America, LLC, an Indiana limited liability company (?Premiere?, and collectively with PBS, the ?Borrower?), Performant Financial Corpor
March 29, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
March 22, 2021	EX-4.2	Description of Registrant’s Securities Registered under Section 12 of the Securities Exchange Act of 1934 Exhibit 4.2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Performant Financial Corporation (?Performant? or ?our?) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?): our Common Stock. Description of Common Stock The following description of our Common Stock is a summary and does not purport to
March 22, 2021	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, LLC. California Premiere Credit of North America, LLC. Indiana Healthcare Billing Administrators, LLC. Indiana
March 22, 2021	10-K	Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
March 16, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
March 16, 2021	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) Assets December 31, 2020 December 31, 2019 Current assets: Cash and cash equivalents $ 16,043 $ 3,373 Restricted cash 2 Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2020 Livermore, Calif., March 16, 2021 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its fourth quarter and full year ended December 3
March 2, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2021 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission
March 2, 2021	EX-99.1	– 1 – IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE SHIVA STEIN, individually and on behalf of all others similarly situated stockholders of PERFORMANT FINANCIAL CORPORATION, Plaintiff, v. PERFORMANT FINANCIAL CORPORATION, LISA C. IM, BRADLEY M. ? 1 ? IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE SHIVA STEIN, individually and on behalf of all others similarly situated stockholders of PERFORMANT FINANCIAL CORPORATION, Plaintiff, v.
December 30, 2020	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2020 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission
December 30, 2020	EX-99.1	Performant Receives Continued Listing Standard Notice from Nasdaq Performant Receives Continued Listing Standard Notice from Nasdaq LIVERMORE, Calif.
December 10, 2020	SC 13G/A	PFMT / Performant Financial Corp / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7 )* Performant Financial Corp (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) November 30, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t
November 12, 2020	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERF
November 10, 2020	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third quarter 2020 Livermore, Calif., November 10, 2020 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its third quarter ended September 30, 2020:
November 10, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2020 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation)
October 26, 2020	SC 13D/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP NUMBER) Phil Frohlich 1924 South Utica Ave., Suite #1120 Tulsa, Oklahoma 74104-6429 (918) 747-3412 (Name, Address
October 19, 2020	8-K/A	Submission of Matters to a Vote of Security Holders - 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-3
August 12, 2020	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0
August 11, 2020	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2020 Livermore, Calif., August 11, 2020 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its second quarter ended June 30, 2020: Secon
August 11, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2020 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (C
July 17, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission Fil
June 1, 2020	DEFA14A	- DEFA14A DEFA14A 1 performant-defa14aaddition.htm DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Defi
June 1, 2020	DEF 14A	- DEF 14A DEF 14A 1 a2020proxydef.htm DEF 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additi
May 28, 2020	10-Q	Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:
May 22, 2020	10-K/A	Annual Report - 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-
May 22, 2020	PRE 14A	- PRE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Pursuant to § 240.
May 19, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8k03312020.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2020 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdicti
May 19, 2020	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2020 Livermore, Calif., May 19, 2020 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its first quarter ended March 31, 2020: First Qua
May 15, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission File
May 12, 2020	EX-4	CONFIRMING STATEMENT EX-4 CUSIP No. 71377E105 Page 1 of 1 Pages Exhibit 4 CONFIRMING STATEMENT This Statement confirms that the undersigned has authorized and designated Thomas E. Lynch and Justin C. Jacobs, each acting singly, to execute and file on the undersigned’s behalf all Forms 3, 4 and 5 and Schedule 13D (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities an
May 12, 2020	SC 13D/A	PFMT / Performant Financial Corp / Mill Road Capital II, L.P. - SC 13D AMENDMENT #1 Activist Investment SC 13D Amendment #1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 7, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
April 29, 2020	10-K	Annual Report - 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
April 29, 2020	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, LLC. California Premiere Credit of North America, LLC. Indiana Healthcare Billing Administrators, LLC. Indiana
April 29, 2020	EX-4.2	Description of Registrant’s Securities Registered under Section 12 of the Securities Exchange Act of 1934 Exhibit 4.2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT Performant Financial Corporation (“Performant” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our Common Stock. Description of Common Stock The following description of our Common Stock is a summary and does not purport to
April 29, 2020	8-K	Other Events 8-K 1 pfmt-8xkxcovidproxydelayap.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction o
April 22, 2020	EX-99.1	Performant Receives Continued Listing Standard Notice from Nasdaq Exhibit 99.1 Performant Receives Continued Listing Standard Notice from Nasdaq LIVERMORE, Calif., April 22, 2020 - Performant Financial Corporation (Nasdaq:PFMT),(“the Company”), a provider of technology-enabled recovery and related analytics services, announced today that on April 17, 2020, the Company received a letter from the Listing Qualifications Department of the NASDAQ Stock Market (“NASDA
April 22, 2020	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission Fi
March 30, 2020	EX-99.1	Performant Financial Corporation Provides Update on Form 10-K Filing; Announces Changes to its Board of Directors Exhibit 99.1 Performant Financial Corporation Provides Update on Form 10-K Filing; Announces Changes to its Board of Directors Livermore, Calif., March 30, 2020 - Performant Financial Corporation (Nasdaq: PFMT), (the “Company”), a leading provider of technology-enabled recovery and related analytics services in the United States, today provided an update with regards to its Form 10-K for the year
March 30, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events 8-K 1 pfmt8-kcovid10xkdelaystein.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction o
March 26, 2020	SC 13D	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP NUMBER) Phil Frohlich 1924 South Utica Ave., Suite #1120 Tulsa, Oklahoma 74104-6429 (918) 747-3412 (Name, Address a
March 20, 2020	EX-99.1	Joint Filing Agreement Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that the Statement on Schedule 13G dated March 20, 2020 with respect to the Common Stock, $0.0001 par value per share, of Performant Financial Corporation, and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rul
March 20, 2020	SC 13G	PFMT / Performant Financial Corp / 22NW, LP Passive Investment SC 13G 1 sc13g1068000803192020.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )1 Performant Financial Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Cl
March 17, 2020	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) Assets December 31, 2019 December 31, 2018 Current assets: Cash and cash equivalents $ 3,373 $ 5,462 Restricted cash 1, EX-99.1 2 ex991pressrelease12312019.htm EXHIBIT 99.1 Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2019 Livermore, Calif., March 17, 2020 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its fourt
March 17, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8k12312019.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdic
March 3, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2019 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission
March 3, 2020	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Reconciliation of Non-GAAP Results (In thousands) (Unaudited) We are providing the following preliminary estimates of our financial results for the three months ended December 31, 2019 and year ended EX-99.1 2 a2019q4and2020guidanceupda.htm EXHIBIT 99.1 Performant Provides an Update to EBITDA Guidance for Fourth Quarter 2019, Announces Initial 2020 Annual Guidance Ranges; Announces Fourth Quarter and Full Year 2019 Earnings Call Details LIVERMORE, Calif., February 26, 2020 - Performant Financial Corporation (Nasdaq:PFMT),(“the Company”), a provider of technology-enabled recovery and related an
February 27, 2020	EX-99.1	22NW PUBLICLY RELEASES LETTER TO BOARD OF PERFORMANT FINANCIAL CORPORATION Makes Cleansing Disclosure Pursuant to Non-Disclosure Agreement with Performant Exhibit 99.1 22NW PUBLICLY RELEASES LETTER TO BOARD OF PERFORMANT FINANCIAL CORPORATION Makes Cleansing Disclosure Pursuant to Non-Disclosure Agreement with Performant SEATTLE, WA, February 27, 2020 – 22NW, LP (“22NW” or “we”), one of the largest stockholders of Performant Financial Corporation (“Performant” or the “Company”) (NASDAQ:PFMT), with ownership of approximately 6.2% of the Company’s out
February 27, 2020	SC 13D/A	PFMT / Performant Financial Corp / 22NW, LP - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment SC 13D/A 1 sc13da11068000802262020.htm AMENDMENT NO. 1 TO THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par
February 13, 2020	SC 13G/A	PFMT / Performant Financial Corp / Ecmc Group, Inc. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Performant Financial Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
February 7, 2020	SC 13G/A	PFMT / Performant Financial Corp / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Performant Financial Corp (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate
January 23, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2020 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission
January 23, 2020	EX-99.1	Performant Regains Continued Listing Standard Compliance with Nasdaq EXHIBIT 99.1 Performant Regains Continued Listing Standard Compliance with Nasdaq LIVERMORE, Calif., January 23, 2020 - Performant Financial Corporation (Nasdaq:PFMT),(“the Company”), a provider of technology-enabled recovery and related analytics services, announced today that it received a letter dated January 22, 2020 from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has
January 21, 2020	SC 13G/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 5) (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Performant Financial Corporation (Name of Issuer) Common Stock, par value $.0001 per share (Title of Class of Securities) 71377E105 (CUSIP N
January 7, 2020	CORRESP	PFMT / Performant Financial Corp CORRESP - - CORRESP 1 filename1.htm PERFORMANT FINANCIAL CORPORATION 333 North Canyons Parkway Livermore, California 94551 January 7, 2020 VIA FACSIMILE AND ELECTRONIC SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Performant Financial Corporation - Registration Statement – Form S-3 Registration Number: 333-235660 Ladies and Gentleme
January 2, 2020	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8-K 1 performant-8xkxjanx2x2020.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2019 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction
December 27, 2019	CORRESP	PFMT / Performant Financial Corp CORRESP - - PERFORMANT FINANCIAL CORPORATION 333 North Canyons Parkway Livermore, California 94551 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F.
December 20, 2019	S-3	PFMT / Performant Financial Corp S-3 - - S-3 As filed with the Securities and Exchange Commission on December 20, 2019 Registration No.
December 13, 2019	EX-99.1	JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, $0.0001 par value per share, of Performant Financial Corporation, a Delaware corporat
December 13, 2019	SC 13D	PFMT / Performant Financial Corp / 22NW, LP - SCHEDULE 13D Activist Investment SC 13D 1 sc13d1068000812122019.htm SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Cl
November 20, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2019 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission
November 14, 2019	10-Q	PFMT / Performant Financial Corp 10-Q - Quarterly Report - 10-Q 10-Q 1 a10q09302019.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period
November 12, 2019	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third Quarter 2019 Livermore, Calif., November 12, 2019 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its third quarter ended September 30, 2019:
November 12, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8k09302019.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2019 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other juris
August 14, 2019	10-Q	PFMT / Performant Financial Corp 10-Q - Quarterly Report - 10-Q 10-Q 1 a10q06302019.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from
August 13, 2019	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2019 Livermore, Calif., August 13, 2019 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its second quarter ended June 30, 2019: Secon
August 13, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2019 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (C
July 10, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2019 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission File
June 19, 2019	SC 13G/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Passive Investment SC 13G/A 1 sc13gaperformant.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Amendment No. 4) (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Performant Financial Corporation (Name of Issuer) Common Stock, par value $.0001 per share (Title of Class o
June 7, 2019	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2019 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission File
May 20, 2019	SC 13G/A	PFMT / Performant Financial Corp / Ecmc Group, Inc. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Performant Financial Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) May 15, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
May 16, 2019	DEFA14A	PFMT / Performant Financial Corp DEFA14A DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.
May 14, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2019 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 001-35628 (Commission File
May 14, 2019	10-Q	PFMT / Performant Financial Corp 10-Q Quarterly Report 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number:
May 7, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8k03312019.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2019 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdictio
May 7, 2019	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) EX-99.1 2 ex03312019991pressrelease.htm EXHIBIT 99.1 Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2019 Livermore, Calif., May 7, 2019 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results f
April 24, 2019	DEFA14A	PFMT / Performant Financial Corp DEFA14A DEFA14A 1 performant-def14aadditiona.htm DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Defi
April 24, 2019	DEF 14A	PFMT / Performant Financial Corp DEF 14A DEF 14A 1 a2019proxy.htm DEF 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additiona
April 1, 2019	EX-10.16	Amendment No. 3 to Credit Agreement, dated as of March 21, 2019, by and among Performant Business Services, Inc. and ECMC Group, Inc. Exhibit 10.16 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (the “Amendment”), dated as of March 21, 2019, is by and among Performant Business Services, Inc., a Nevada corporation (the “Borrower”), and ECMC Group, Inc., a Delaware non-profit corporation (the “Lender”). RECITALS: A. The Borrower and Lender are parties to that certain Credit Agreement dated as of Augus
April 1, 2019	EX-21	List of Subsidiaries Exhibit 21 SUBSIDIARIES Company Name State of Incorporation Performant Business Services, Inc. Nevada Performant Recovery, Inc. California Performant Technologies, Inc. California Performant Europe Ltd. London, UK Premiere Credit of North America, LLC. Indiana Healthcare Billing Administrators, LLC. Indiana
April 1, 2019	10-K	PFMT / Performant Financial Corp 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35
March 26, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2019 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
March 26, 2019	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) (Unaudited) Assets December 31, 2018 December 31, 2017 Current assets: Cash and cash equivalents $ 5,462 $ 21,731 Restricted cash 1 Performant Financial Corporation Announces Financial Results for Fourth Quarter and Full Year 2018 Livermore, Calif.
February 13, 2019	SC 13G/A	PFMT / Performant Financial Corp / Ecmc Group, Inc. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Performant Financial Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
February 11, 2019	SC 13G/A	PFMT / Performant Financial Corp / PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A (Amendment No.
February 8, 2019	SC 13G	PFMT / Performant Financial Corp / 22NW, LP Passive Investment SC 13G 1 p117192sc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Performant Finl Corp (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 71377E105 (CUSIP Number) 12/31/2018 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate th
February 4, 2019	SC 13G/A	PFMT / Performant Financial Corp / Invesco Ltd. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Performant Financial Corp (Name of Issuer) Common Stock (Title of Class of Securities) 71377E105 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t
November 14, 2018	10-Q	PFMT / Performant Financial Corp 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numb
November 9, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (
November 9, 2018	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) EX-99.1 2 ex09302018991pressrelease.htm EXHIBIT 99.1 Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Third Quarter 2018 Livermore, Calif., November 9, 2018 - Performant Financial Corporation (Nasdaq: PFMT), (the "Company"), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial resu
October 9, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 5, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (C
September 21, 2018	EX-16.1	Letter dated September 21, 2018 from KPMG to the Securities and Exchange Commission. Exhibit 16.1 [KPMG Letterhead] KPMG LLP Suite 1400 55 Second Street San Francisco, CA 94105 September 21, 2018 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously principal accountants for Performant Financial Corporation (the Company) and, under the date of March 14, 2018, we reported on the consolidated financial statements of Performant Financial C
September 21, 2018	8-K	Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation)
August 10, 2018	EX-10.1	Amendment No. 2 to Credit Agreement, dated as of August 31, 2018, by and among Performant Business Services, Inc. and ECMC Group, Inc. (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed August 10, 2018) Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of August , 2018 (the “Amendment”), is by and among Performant Business Services, Inc., a Nevada corporation (the “Borrower”) and ECMC Group, Inc., a Delaware non-profit corporation (the “Lender”). RECITALS: A. The Borrower and Lender are parties to that certain Credit Agreement dated as of August
August 10, 2018	10-Q	PFMT / Performant Financial Corp 10-Q (Quarterly Report) 10-Q 1 a10q06302018.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from
August 9, 2018	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for Second Quarter 2018 Recently signed an agreement to acquire Premiere Credit of North America Livermore, Calif., August 9, 2018 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial re
August 9, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Co
June 14, 2018	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Com
May 9, 2018	10-Q	PFMT / Performant Financial Corp 10-Q (Quarterly Report) 10-Q 1 a10q03312018.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro
May 8, 2018	EX-99.1	PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except per share amounts) Exhibit 99.1 Performant Financial Corporation Announces Financial Results for First Quarter 2018 Livermore, Calif., May 8, 2018 - Performant Financial Corporation (Nasdaq: PFMT), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its first quarter ended March 31, 2018: First Quarter Financial Hig
May 8, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8k03312018.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdictio
May 4, 2018	8-K	Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2018 Performant Financial Corporation (Exact name of registrant as specified in its charter) Delaware 001-35628 20-0484934 (State or other jurisdiction of incorporation) (Commi
April 26, 2018	DEFA14A	PFMT / Performant Financial Corp DEFA14A DEFA14A 1 performant-def14aadditiona.htm DEFA14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Defi
April 26, 2018	DEF 14A	PFMT / Performant Financial Corp DEF 14A DEF 14A 1 a2018proxy.htm DEF 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additiona
April 26, 2018	SC 13D/A	PFMT / Performant Financial Corp / Philadelphia Financial Management of San Francisco, LLC Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Performant Financial Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 71377E105 (CUSIP Number) Rachael Clarke Philadelphia Financial Management of San Francisco, LLC 450 Sansome Street, Suite 1500 San
March 14, 2018	10-K	PFMT / Performant Financial Corp 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35

PFMT / Performant Healthcare, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings